CalciMedica, Inc. (CALC) stock
CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.17−0.05 (-4.10%)
Close on Nov 18, 2026Market cap $39.95MP/E –Yield –
CalciMedica net income
Net income is the profit left for shareholders after every expense, interest and tax.
CalciMedica's net income for the twelve months ending Jun 30, 2026 was -$21.24M. For fiscal 2025 it was -$29.56M. The highest annual figure on record is -$7.82M in fiscal 2022.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$29.56M | – |
| FY2024 | Dec 31, 2024 | -$13.70M | – |
| FY2023 | Dec 31, 2023 | -$34.36M | – |
| FY2022 | Dec 31, 2022 | -$7.82M | – |
| FY2021 | Dec 31, 2021 | -$35.82M | – |
| FY2020 | Dec 31, 2020 | -$27.53M | – |
| FY2019 | Dec 31, 2019 | -$37.04M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$7.65M | – |
| Q1 FY2026 | Mar 31, 2026 | $4.98M | – |
| Q4 FY2025 | Dec 31, 2025 | -$10.76M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.80M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.96M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.04M | -3978.5% |
| Q4 FY2024 | Dec 31, 2024 | -$4.26M | – |
| Q3 FY2024 | Sep 30, 2024 | -$5.62M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.95M | – |
| Q1 FY2024 | Mar 31, 2024 | $130.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.15M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.62M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.30M | – |
| Q1 FY2023 | Mar 31, 2023 | -$19.29M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.03M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.63M | – |
| Q4 FY2021 | Dec 31, 2021 | -$8.68M | – |
| Q3 FY2021 | Sep 30, 2021 | -$7.99M | – |
| Q2 FY2021 | Jun 30, 2021 | -$7.71M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.45M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.15M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.72M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.87M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.79M | – |
| Q4 FY2019 | Dec 31, 2019 | -$10.27M | – |
| Q3 FY2019 | Sep 30, 2019 | -$10.21M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.26M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.30M | – |
See a number that looks wrong?